APO Research
Talk to an analyst

APO RESEARCH · REPORT

Pharmacovigilance and Drug Safety Software

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Pharmacovigilance and Drug Safety Software Market Outlook and Growth Opportunities 2026

15 April 2026Not stated

Choose your research edition.

Industry ResearchPharmacovigilance and Drug Safety Software Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Pharmacovigilance and Drug Safety Software Industry Growth and Trends Forecast to 2032110 pages · $3,450 USDMarket StructureGlobal Pharmacovigilance and Drug Safety Software Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Pharmacovigilance and Drug Safety Software Market Outlook and Growth Opportunities 2026$4,250 USDMarket Analysis & ForecastGlobal Pharmacovigilance and Drug Safety Software Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Pharmacovigilance and Drug Safety Software market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Pharmacovigilance and Drug Safety Software is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Pharmacovigilance and Drug Safety Software market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Pharmacovigilance and Drug Safety Software market include Oracle, Veeva Systems, ArisGlobal, IQVIA, EXTEDO, RxLogix, Ennov, Uppsala Monitoring Centre and Medidata, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Pharmacovigilance and Drug Safety Software market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Pharmacovigilance and Drug Safety Software and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Pharmacovigilance and Drug Safety Software revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Pharmacovigilance and Drug Safety Software market.

Pharmacovigilance and Drug Safety Software Segment by Company

Oracle

Veeva Systems

ArisGlobal

IQVIA

EXTEDO

RxLogix

Ennov

Uppsala Monitoring Centre

Medidata

Clarivate

AB Cube

Cloudbyz

Cognizant Technology

Taimei Technology

eMedyun

Bioknow

Singedi Health

Pharmacovigilance and Drug Safety Software Segment by Type

Adverse Event Reporting Software

Drug Safety Audits Software

Issue Tracking Software

Fully Integrated Software

Pharmacovigilance and Drug Safety Software Segment by Application

Pharma and Biotech Companies

Contract Research Organizations (CROs)

Business Process Outsourcing (BPO) Firms

Pharmacovigilance Service Providers

Others

Pharmacovigilance and Drug Safety Software Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Pharmacovigilance and Drug Safety Software status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Pharmacovigilance and Drug Safety Software key companies, revenue, market share, and recent developments.

3. To split the Pharmacovigilance and Drug Safety Software breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Pharmacovigilance and Drug Safety Software market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Pharmacovigilance and Drug Safety Software significant trends, drivers, influence factors in global and regions.

6. To analyze Pharmacovigilance and Drug Safety Software competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Pharmacovigilance and Drug Safety Software market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Pharmacovigilance and Drug Safety Software and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Pharmacovigilance and Drug Safety Software.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Pharmacovigilance and Drug Safety Software industry.

Chapter 3: Detailed analysis of Pharmacovigilance and Drug Safety Software company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Pharmacovigilance and Drug Safety Software in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Pharmacovigilance and Drug Safety Software in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Pharmacovigilance and Drug Safety Software Industry Trends Table 2. Pharmacovigilance and Drug Safety Software Industry Drivers Table 3. Pharmacovigilance and Drug Safety Software Industry Opportunities and Challenges Table 4. Pharmacovigilance and Drug Safety Software Industry Restraints Table 5. Global Pharmacovigilance and Drug Safety Software Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Pharmacovigilance and Drug Safety Software Revenue Share by Company (2021-2026) Table 7. Global Pharmacovigilance and Drug Safety Software Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Pharmacovigilance and Drug Safety Software Key Company Manufacturing Base & Headquarters Table 9. Global Pharmacovigilance and Drug Safety Software Company, Product Type & Application Table 10. Global Pharmacovigilance and Drug Safety Software Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Pharmacovigilance and Drug Safety Software by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Adverse Event Reporting Software Table 15. Significant Companies of Drug Safety Audits Software Table 16. Significant Companies of Issue Tracking Software Table 17. Significant Companies of Fully Integrated Software Table 18. Global Pharmacovigilance and Drug Safety Software Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 19. Global Pharmacovigilance and Drug Safety Software Sales Value by Type (2021-2026) & (US$ Million) Table 20. Global Pharmacovigilance and Drug Safety Software Sales Value by Type (2027-2032) & (US$ Million) Table 21. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Type (2021-2026) Table 22. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Type (2027-2032) Table 23. Significant Companies of Pharma and Biotech Companies Table 24. Significant Companies of Contract Research Organizations (CROs) Table 25. Significant Companies of Business Process Outsourcing (BPO) Firms Table 26. Significant Companies of Pharmacovigilance Service Providers Table 27. Significant Companies of Others Table 28. Global Pharmacovigilance and Drug Safety Software Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Pharmacovigilance and Drug Safety Software Sales Value by Application (2021-2026) & (US$ Million) Table 30. Global Pharmacovigilance and Drug Safety Software Sales Value by Application (2027-2032) & (US$ Million) Table 31. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Application (2021-2026) Table 32. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Application (2027-2032) Table 33. Global Pharmacovigilance and Drug Safety Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Pharmacovigilance and Drug Safety Software Sales Value by Region (2021-2026) & (US$ Million) Table 35. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Region (2021-2026) Table 36. Global Pharmacovigilance and Drug Safety Software Sales Value by Region (2027-2032) & (US$ Million) Table 37. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Region (2027-2032) Table 38. Global Pharmacovigilance and Drug Safety Software Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Pharmacovigilance and Drug Safety Software Sales Value by Country (2021-2026) & (US$ Million) Table 40. Global Pharmacovigilance and Drug Safety Software Sales Value Market Share by Country (2021-2026) Table 41. Global Pharmacovigilance and Drug Safety Software Sales Value by Country (2027-2032) & (US$ Million) Table 42. Global Pharmacovigilance and Drug Safety Software Sales Value Market Share by Country (2027-2032) Table 43. Oracle Company Information Table 44. Oracle Business Overview Table 45. Oracle Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Oracle Pharmacovigilance and Drug Safety Software Product Portfolio Table 47. Oracle Recent Development Table 48. Veeva Systems Company Information Table 49. Veeva Systems Business Overview Table 50. Veeva Systems Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. Veeva Systems Pharmacovigilance and Drug Safety Software Product Portfolio Table 52. Veeva Systems Recent Development Table 53. ArisGlobal Company Information Table 54. ArisGlobal Business Overview Table 55. ArisGlobal Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. ArisGlobal Pharmacovigilance and Drug Safety Software Product Portfolio Table 57. ArisGlobal Recent Development Table 58. IQVIA Company Information Table 59. IQVIA Business Overview Table 60. IQVIA Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. IQVIA Pharmacovigilance and Drug Safety Software Product Portfolio Table 62. IQVIA Recent Development Table 63. EXTEDO Company Information Table 64. EXTEDO Business Overview Table 65. EXTEDO Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. EXTEDO Pharmacovigilance and Drug Safety Software Product Portfolio Table 67. EXTEDO Recent Development Table 68. RxLogix Company Information Table 69. RxLogix Business Overview Table 70. RxLogix Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. RxLogix Pharmacovigilance and Drug Safety Software Product Portfolio Table 72. RxLogix Recent Development Table 73. Ennov Company Information Table 74. Ennov Business Overview Table 75. Ennov Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Ennov Pharmacovigilance and Drug Safety Software Product Portfolio Table 77. Ennov Recent Development Table 78. Uppsala Monitoring Centre Company Information Table 79. Uppsala Monitoring Centre Business Overview Table 80. Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Product Portfolio Table 82. Uppsala Monitoring Centre Recent Development Table 83. Medidata Company Information Table 84. Medidata Business Overview Table 85. Medidata Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Medidata Pharmacovigilance and Drug Safety Software Product Portfolio Table 87. Medidata Recent Development Table 88. Clarivate Company Information Table 89. Clarivate Business Overview Table 90. Clarivate Pharmacovigilance and Drug Safety Software Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Clarivate Pharmacovigilance and Drug Safety Software Product Portfolio Table 92. Clarivate Recent Development Table 93. AB Cube Company Information Table 94. AB Cube Business Overview Table 95. AB Cube Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. AB Cube Pharmacovigilance and Drug Safety Software Product Portfolio Table 97. AB Cube Recent Development Table 98. Cloudbyz Company Information Table 99. Cloudbyz Business Overview Table 100. Cloudbyz Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Cloudbyz Pharmacovigilance and Drug Safety Software Product Portfolio Table 102. Cloudbyz Recent Development Table 103. Cognizant Technology Company Information Table 104. Cognizant Technology Business Overview Table 105. Cognizant Technology Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Cognizant Technology Pharmacovigilance and Drug Safety Software Product Portfolio Table 107. Cognizant Technology Recent Development Table 108. Taimei Technology Company Information Table 109. Taimei Technology Business Overview Table 110. Taimei Technology Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Taimei Technology Pharmacovigilance and Drug Safety Software Product Portfolio Table 112. Taimei Technology Recent Development Table 113. eMedyun Company Information Table 114. eMedyun Business Overview Table 115. eMedyun Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. eMedyun Pharmacovigilance and Drug Safety Software Product Portfolio Table 117. eMedyun Recent Development Table 118. Bioknow Company Information Table 119. Bioknow Business Overview Table 120. Bioknow Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 121. Bioknow Pharmacovigilance and Drug Safety Software Product Portfolio Table 122. Bioknow Recent Development Table 123. Singedi Health Company Information Table 124. Singedi Health Business Overview Table 125. Singedi Health Pharmacovigilance and Drug Safety Software Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 126. Singedi Health Pharmacovigilance and Drug Safety Software Product Portfolio Table 127. Singedi Health Recent Development Table 128. Research Programs/Design for This Report Table 129. Authors List of This Report Table 130. Secondary Sources Table 131. Primary Sources List of Figures Figure 1. Pharmacovigilance and Drug Safety Software Product Image Figure 2. Global Pharmacovigilance and Drug Safety Software Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Pharmacovigilance and Drug Safety Software Market Size (2021-2032) & (US$ Million) Figure 4. Global Pharmacovigilance and Drug Safety Software Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Adverse Event Reporting Software Image Figure 8. Drug Safety Audits Software Image Figure 9. Issue Tracking Software Image Figure 10. Fully Integrated Software Image Figure 11. Global Pharmacovigilance and Drug Safety Software Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Pharmacovigilance and Drug Safety Software Sales Value Share 2021 VS 2025 VS 2032 Figure 13. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Type (2021-2032) Figure 14. Pharma and Biotech Companies Image Figure 15. Contract Research Organizations (CROs) Image Figure 16. Business Process Outsourcing (BPO) Firms Image Figure 17. Pharmacovigilance Service Providers Image Figure 18. Others Image Figure 19. Global Pharmacovigilance and Drug Safety Software Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Pharmacovigilance and Drug Safety Software Sales Value Share 2021 VS 2025 VS 2032 Figure 21. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Application (2021-2032) Figure 22. Global Pharmacovigilance and Drug Safety Software Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 23. Global Pharmacovigilance and Drug Safety Software Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 24. North America Pharmacovigilance and Drug Safety Software Sales Value (2021-2032) & (US$ Million) Figure 25. North America Pharmacovigilance and Drug Safety Software Sales Value Share by Country (%), 2025 VS 2032 Figure 26. Europe Pharmacovigilance and Drug Safety Software Sales Value (2021-2032) & (US$ Million) Figure 27. Europe Pharmacovigilance and Drug Safety Software Sales Value Share by Country (%), 2025 VS 2032 Figure 28. Asia-Pacific Pharmacovigilance and Drug Safety Software Sales Value (2021-2032) & (US$ Million) Figure 29. Asia-Pacific Pharmacovigilance and Drug Safety Software Sales Value Share by Country (%), 2025 VS 2032 Figure 30. South America Pharmacovigilance and Drug Safety Software Sales Value (2021-2032) & (US$ Million) Figure 31. South America Pharmacovigilance and Drug Safety Software Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Middle East & Africa Pharmacovigilance and Drug Safety Software Sales Value (2021-2032) & (US$ Million) Figure 33. Middle East & Africa Pharmacovigilance and Drug Safety Software Sales Value Share by Country (%), 2025 VS 2032 Figure 34. USA Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 35. USA Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 36. USA Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 37. Canada Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 38. Canada Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 39. Canada Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 40. Mexico Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. Mexico Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. Mexico Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Germany Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Germany Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Germany Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. France Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. France Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. France Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. U.K. Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. U.K. Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. U.K. Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. Italy Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. Italy Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. Italy Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. Spain Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. Spain Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. Spain Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Russia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Russia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Russia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Netherlands Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Netherlands Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Netherlands Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. China Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. China Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. China Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Japan Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Japan Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Japan Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. South Korea Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. South Korea Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. South Korea Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. India Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. India Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. India Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. Australia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. Australia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. Australia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Brazil Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Brazil Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Brazil Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Argentina Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Argentina Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Argentina Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Chile Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Chile Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Chile Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Colombia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Colombia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Colombia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Peru Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Peru Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Peru Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Israel Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Israel Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Israel Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. UAE Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. UAE Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. UAE Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Turkey Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Turkey Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Turkey Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. Iran Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. Iran Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. Iran Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Egypt Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Egypt Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Egypt Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Years Considered Figure 119. Research Process Figure 120. Key Executives Interviewed

Scope & coverage.

Types
  • Adverse Event Reporting Software
  • Drug Safety Audits Software
  • Issue Tracking Software
  • Fully Integrated Software
Applications
  • Pharma and Biotech Companies
  • Contract Research Organizations (CROs)
  • Business Process Outsourcing (BPO) Firms
  • Pharmacovigilance Service Providers
  • Others
Companies covered
  • Oracle
  • Veeva Systems
  • ArisGlobal
  • IQVIA
  • EXTEDO
  • RxLogix
  • Ennov
  • Uppsala Monitoring Centre
  • Medidata
  • Clarivate
  • AB Cube
  • Cloudbyz
  • Cognizant Technology
  • Taimei Technology
  • eMedyun
  • Bioknow
  • Singedi Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Pharmacovigilance and Drug Safety Software Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Pharmacovigilance and Drug Safety Software Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Pharmacovigilance and Drug Safety Software Market Dynamics
  1. 2.1 Pharmacovigilance and Drug Safety Software Industry Trends
  2. 2.2 Pharmacovigilance and Drug Safety Software Industry Drivers
  3. 2.3 Pharmacovigilance and Drug Safety Software Industry Opportunities and Challenges
  4. 2.4 Pharmacovigilance and Drug Safety Software Industry Restraints
3 Pharmacovigilance and Drug Safety Software Market by Company
  1. 3.1 Global Pharmacovigilance and Drug Safety Software Company Revenue Ranking in 2025
  2. 3.2 Global Pharmacovigilance and Drug Safety Software Revenue by Company (2021-2026)
  3. 3.3 Global Pharmacovigilance and Drug Safety Software Company Ranking (2024-2026)
  4. 3.4 Global Pharmacovigilance and Drug Safety Software Company Manufacturing Base and Headquarters
  5. 3.5 Global Pharmacovigilance and Drug Safety Software Company Product Type and Application
  6. 3.6 Global Pharmacovigilance and Drug Safety Software Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Pharmacovigilance and Drug Safety Software Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Pharmacovigilance and Drug Safety Software Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Pharmacovigilance and Drug Safety Software Market by Type
  1. 4.1 Pharmacovigilance and Drug Safety Software Type Introduction
  2. 4.1.1 Adverse Event Reporting Software
  3. 4.1.2 Drug Safety Audits Software
  4. 4.1.3 Issue Tracking Software
  5. 4.1.4 Fully Integrated Software
  6. 4.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Type
  7. 4.2.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Type (2021-2032)
  9. 4.2.3 Global Pharmacovigilance and Drug Safety Software Sales Value Share by Type (2021-2032)
5 Pharmacovigilance and Drug Safety Software Market by Application
  1. 5.1 Pharmacovigilance and Drug Safety Software Application Introduction
  2. 5.1.1 Pharma and Biotech Companies
  3. 5.1.2 Contract Research Organizations (CROs)
  4. 5.1.3 Business Process Outsourcing (BPO) Firms
  5. 5.1.4 Pharmacovigilance Service Providers
  6. 5.1.5 Others
  7. 5.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Application
  8. 5.2.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Application (2021 VS 2025 VS 2032)
  9. 5.2.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Application (2021-2032)
  10. 5.2.3 Global Pharmacovigilance and Drug Safety Software Sales Value Share by Application (2021-2032)
6 Pharmacovigilance and Drug Safety Software Regional Value Analysis
  1. 6.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Region (2021-2032)
  3. 6.2.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Region: 2021-2026
  4. 6.2.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Pharmacovigilance and Drug Safety Software Sales Value (2021-2032)
  7. 6.3.2 North America Pharmacovigilance and Drug Safety Software Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Pharmacovigilance and Drug Safety Software Sales Value (2021-2032)
  10. 6.4.2 Europe Pharmacovigilance and Drug Safety Software Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Pharmacovigilance and Drug Safety Software Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Pharmacovigilance and Drug Safety Software Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Pharmacovigilance and Drug Safety Software Sales Value (2021-2032)
  16. 6.6.2 South America Pharmacovigilance and Drug Safety Software Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Pharmacovigilance and Drug Safety Software Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Pharmacovigilance and Drug Safety Software Sales Value Share by Country, 2025 VS 2032
7 Pharmacovigilance and Drug Safety Software Country-level Value Analysis
  1. 7.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Country (2021-2032)
  3. 7.2.1 Global Pharmacovigilance and Drug Safety Software Sales Value by Country (2021-2026)
  4. 7.2.2 Global Pharmacovigilance and Drug Safety Software Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Pharmacovigilance and Drug Safety Software Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Pharmacovigilance and Drug Safety Software Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Pharmacovigilance and Drug Safety Software Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Oracle
  2. 8.1.1 Oracle Company Information
  3. 8.1.2 Oracle Business Overview
  4. 8.1.3 Oracle Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Oracle Pharmacovigilance and Drug Safety Software Product Portfolio
  6. 8.1.5 Oracle Recent Developments
  7. 8.2 Veeva Systems
  8. 8.2.1 Veeva Systems Company Information
  9. 8.2.2 Veeva Systems Business Overview
  10. 8.2.3 Veeva Systems Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Veeva Systems Pharmacovigilance and Drug Safety Software Product Portfolio
  12. 8.2.5 Veeva Systems Recent Developments
  13. 8.3 ArisGlobal
  14. 8.3.1 ArisGlobal Company Information
  15. 8.3.2 ArisGlobal Business Overview
  16. 8.3.3 ArisGlobal Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  17. 8.3.4 ArisGlobal Pharmacovigilance and Drug Safety Software Product Portfolio
  18. 8.3.5 ArisGlobal Recent Developments
  19. 8.4 IQVIA
  20. 8.4.1 IQVIA Company Information
  21. 8.4.2 IQVIA Business Overview
  22. 8.4.3 IQVIA Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  23. 8.4.4 IQVIA Pharmacovigilance and Drug Safety Software Product Portfolio
  24. 8.4.5 IQVIA Recent Developments
  25. 8.5 EXTEDO
  26. 8.5.1 EXTEDO Company Information
  27. 8.5.2 EXTEDO Business Overview
  28. 8.5.3 EXTEDO Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  29. 8.5.4 EXTEDO Pharmacovigilance and Drug Safety Software Product Portfolio
  30. 8.5.5 EXTEDO Recent Developments
  31. 8.6 RxLogix
  32. 8.6.1 RxLogix Company Information
  33. 8.6.2 RxLogix Business Overview
  34. 8.6.3 RxLogix Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  35. 8.6.4 RxLogix Pharmacovigilance and Drug Safety Software Product Portfolio
  36. 8.6.5 RxLogix Recent Developments
  37. 8.7 Ennov
  38. 8.7.1 Ennov Company Information
  39. 8.7.2 Ennov Business Overview
  40. 8.7.3 Ennov Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ennov Pharmacovigilance and Drug Safety Software Product Portfolio
  42. 8.7.5 Ennov Recent Developments
  43. 8.8 Uppsala Monitoring Centre
  44. 8.8.1 Uppsala Monitoring Centre Company Information
  45. 8.8.2 Uppsala Monitoring Centre Business Overview
  46. 8.8.3 Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Uppsala Monitoring Centre Pharmacovigilance and Drug Safety Software Product Portfolio
  48. 8.8.5 Uppsala Monitoring Centre Recent Developments
  49. 8.9 Medidata
  50. 8.9.1 Medidata Company Information
  51. 8.9.2 Medidata Business Overview
  52. 8.9.3 Medidata Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Medidata Pharmacovigilance and Drug Safety Software Product Portfolio
  54. 8.9.5 Medidata Recent Developments
  55. 8.10 Clarivate
  56. 8.10.1 Clarivate Company Information
  57. 8.10.2 Clarivate Business Overview
  58. 8.10.3 Clarivate Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Clarivate Pharmacovigilance and Drug Safety Software Product Portfolio
  60. 8.10.5 Clarivate Recent Developments
  61. 8.11 AB Cube
  62. 8.11.1 AB Cube Company Information
  63. 8.11.2 AB Cube Business Overview
  64. 8.11.3 AB Cube Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  65. 8.11.4 AB Cube Pharmacovigilance and Drug Safety Software Product Portfolio
  66. 8.11.5 AB Cube Recent Developments
  67. 8.12 Cloudbyz
  68. 8.12.1 Cloudbyz Company Information
  69. 8.12.2 Cloudbyz Business Overview
  70. 8.12.3 Cloudbyz Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Cloudbyz Pharmacovigilance and Drug Safety Software Product Portfolio
  72. 8.12.5 Cloudbyz Recent Developments
  73. 8.13 Cognizant Technology
  74. 8.13.1 Cognizant Technology Company Information
  75. 8.13.2 Cognizant Technology Business Overview
  76. 8.13.3 Cognizant Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Cognizant Technology Pharmacovigilance and Drug Safety Software Product Portfolio
  78. 8.13.5 Cognizant Technology Recent Developments
  79. 8.14 Taimei Technology
  80. 8.14.1 Taimei Technology Company Information
  81. 8.14.2 Taimei Technology Business Overview
  82. 8.14.3 Taimei Technology Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Taimei Technology Pharmacovigilance and Drug Safety Software Product Portfolio
  84. 8.14.5 Taimei Technology Recent Developments
  85. 8.15 eMedyun
  86. 8.15.1 eMedyun Company Information
  87. 8.15.2 eMedyun Business Overview
  88. 8.15.3 eMedyun Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  89. 8.15.4 eMedyun Pharmacovigilance and Drug Safety Software Product Portfolio
  90. 8.15.5 eMedyun Recent Developments
  91. 8.16 Bioknow
  92. 8.16.1 Bioknow Company Information
  93. 8.16.2 Bioknow Business Overview
  94. 8.16.3 Bioknow Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Bioknow Pharmacovigilance and Drug Safety Software Product Portfolio
  96. 8.16.5 Bioknow Recent Developments
  97. 8.17 Singedi Health
  98. 8.17.1 Singedi Health Company Information
  99. 8.17.2 Singedi Health Business Overview
  100. 8.17.3 Singedi Health Pharmacovigilance and Drug Safety Software Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Singedi Health Pharmacovigilance and Drug Safety Software Product Portfolio
  102. 8.17.5 Singedi Health Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst